• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杜氏肌营养不良症:糖皮质激素对呼吸机使用和行走能力的影响。

Duchenne muscular dystrophy: the effect of glucocorticoids on ventilator use and ambulation.

作者信息

Bach John R, Martinez Daniel, Saulat Bilal

机构信息

Department of Physical Medicine and Rehabilitation, University Hospital, UMDNJ-The New Jersey Medical School, Newark, 07103, USA.

出版信息

Am J Phys Med Rehabil. 2010 Aug;89(8):620-4. doi: 10.1097/PHM.0b013e3181e72207.

DOI:10.1097/PHM.0b013e3181e72207
PMID:20647779
Abstract

OBJECTIVE

To describe the effect of glucocorticoid treatment on age at wheelchair dependence and at dependence on part-time (<23 hrs/day) and continuous noninvasive mechanical ventilation.

DESIGN

In this retrospective study, patients with Duchenne muscular dystrophy who received glucocorticoid therapy were compared with those who did not for ages at wheelchair dependence and when beginning part-time (nocturnal) and continuous noninvasive intermittent positive pressure ventilation (NIV). Respiratory symptoms, end-tidal carbon dioxide, oximetry, and vital capacity were noted every 4-12 mos, and NIV was initiated for symptomatic nocturnal hypoventilation. The daily NIV use increased until some required it continuously to survive.

RESULTS

The 117 untreated patients became wheelchair-dependent at 9.7 +/- 1.3 yrs of age. Four then died from cardiac failure, and five were older than 19 yrs without using NIV. The remaining 108 began nocturnal NIV at 19.2 +/- 3.7 yrs of age. Ninety of the 108 became continuously NIV-dependent at 21.9 +/- 4.5 yrs of age, and the 17 treated with glucocorticoid therapy became wheelchair-dependent significantly later at 10.8 +/- 1.3 yrs of age (P = 0.02). Three died from cardiac failure, and three were older than 19 yrs without using NIV. The remaining 11 began nocturnal NIV at 22.9 +/- 5.3 yrs of age (P = 0.05). Eight of the 11 became continuously NIV-dependent at age 28.9 +/- 7.3 yrs (P = 0.005).

CONCLUSIONS

Intermittent glucocorticoid therapy delays wheelchair dependence and may delay ventilator dependence for patients with Duchenne muscular dystrophy.

摘要

目的

描述糖皮质激素治疗对杜氏肌营养不良症患者出现轮椅依赖、部分时间(<23小时/天)依赖和持续无创机械通气依赖的年龄的影响。

设计

在这项回顾性研究中,将接受糖皮质激素治疗的杜氏肌营养不良症患者与未接受治疗的患者在出现轮椅依赖、开始部分时间(夜间)和持续无创间歇正压通气(NIV)的年龄方面进行比较。每4 - 12个月记录呼吸症状、呼气末二氧化碳、血氧饱和度和肺活量,对于有症状的夜间通气不足则开始使用NIV。每日NIV使用量逐渐增加,直至部分患者需要持续使用以维持生命。

结果

117名未接受治疗的患者在9.7±1.3岁时出现轮椅依赖。其中4人死于心力衰竭,5人年龄超过19岁未使用NIV。其余108人在19.2±3.7岁时开始夜间NIV。108人中的90人在21.9±4.5岁时开始持续依赖NIV,而17名接受糖皮质激素治疗的患者在10.8±1.3岁时出现轮椅依赖的时间显著更晚(P = 0.02)。3人死于心力衰竭,3人年龄超过19岁未使用NIV。其余11人在22.9±5.3岁时开始夜间NIV(P = 0.05)。11人中的8人在28.9±7.3岁时开始持续依赖NIV(P = 0.005)。

结论

间歇性糖皮质激素治疗可延迟杜氏肌营养不良症患者的轮椅依赖,并可能延迟其对呼吸机的依赖。

相似文献

1
Duchenne muscular dystrophy: the effect of glucocorticoids on ventilator use and ambulation.杜氏肌营养不良症:糖皮质激素对呼吸机使用和行走能力的影响。
Am J Phys Med Rehabil. 2010 Aug;89(8):620-4. doi: 10.1097/PHM.0b013e3181e72207.
2
Duchenne muscular dystrophy: life prolongation by noninvasive ventilatory support.杜氏肌营养不良症:通过无创通气支持延长生命
Am J Phys Med Rehabil. 2014 Jul;93(7):595-9. doi: 10.1097/PHM.0000000000000074.
3
Plasma Krebs von den Lungen glycoprotein, lung injury, and noninvasive ventilation in Duchenne muscular dystrophy.血浆 Krebs von den Lungen 糖蛋白、肺损伤与杜氏肌营养不良症的无创通气。
Am J Phys Med Rehabil. 2012 Oct;91(10):831-5. doi: 10.1097/PHM.0b013e31825f1414.
4
Impact of Noninvasive Ventilation on Lung Volumes and Maximum Respiratory Pressures in Duchenne Muscular Dystrophy.无创通气对杜氏肌营养不良症患者肺容量和最大呼吸压力的影响
Respir Care. 2016 Nov;61(11):1530-1535. doi: 10.4187/respcare.04703. Epub 2016 Oct 18.
5
Twenty-four hour noninvasive ventilation in Duchenne muscular dystrophy: a safe alternative to tracheostomy.二十四小时无创通气在杜氏肌营养不良症中的应用:一种优于气管切开术的安全替代方法。
Can Respir J. 2013 Jan-Feb;20(1):e5-9. doi: 10.1155/2013/406163.
6
Functional abilities, respiratory and cardiac function in a large cohort of adults with Duchenne muscular dystrophy treated with glucocorticoids.使用糖皮质激素治疗的大量杜氏肌营养不良症成年患者的功能能力、呼吸和心脏功能。
Eur J Neurol. 2024 Jun;31(6):e16267. doi: 10.1111/ene.16267. Epub 2024 Mar 31.
7
Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy.长期使用类固醇对杜氏肌营养不良症患者咳嗽效率和呼吸肌力量的影响。
Pediatrics. 2007 Feb;119(2):e320-4. doi: 10.1542/peds.2006-1400.
8
Determinants of usage and nonadherence to noninvasive ventilation in children and adults with Duchenne muscular dystrophy.杜氏肌营养不良症患儿和成年患者使用和不遵从无创通气的决定因素。
J Clin Sleep Med. 2021 Oct 1;17(10):1973-1980. doi: 10.5664/jcsm.9400.
9
Impact of Mechanical Ventilation Methods on the Life Perception of Subjects With Duchenne Muscular Dystrophy: French Cross-Sectional Survey.机械通气方式对杜氏肌营养不良症患者生命感知的影响:法国横断面调查。
Respir Care. 2020 Nov;65(11):1712-1720. doi: 10.4187/respcare.07131. Epub 2020 Aug 18.
10
Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study.糖皮质激素对杜氏肌营养不良症患者功能、生活质量和生存的长期影响:一项前瞻性队列研究。
Lancet. 2018 Feb 3;391(10119):451-461. doi: 10.1016/S0140-6736(17)32160-8. Epub 2017 Nov 22.

引用本文的文献

1
Eteplirsen Treatment for Duchenne Muscular Dystrophy: A Qualitative Patient Experience Study.依替膦酸治疗杜氏肌营养不良症:一项定性患者体验研究。
Adv Ther. 2024 Aug;41(8):3278-3298. doi: 10.1007/s12325-024-02915-9. Epub 2024 Jul 3.
2
Population longitudinal analysis of Gait Profile Score and North Star Ambulatory Assessment in children with Duchenne muscular dystrophy.人群纵向分析杜氏肌营养不良症患儿步态曲线评分和北极星步态评估
CPT Pharmacometrics Syst Pharmacol. 2024 May;13(5):891-903. doi: 10.1002/psp4.13126. Epub 2024 Mar 27.
3
Dimethyl fumarate modulates the dystrophic disease program following short-term treatment.
富马酸二甲酯可在短期治疗后调节进行性肌营养不良症的病变进程。
JCI Insight. 2023 Nov 8;8(21):e165974. doi: 10.1172/jci.insight.165974.
4
Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes.利用患者诱导多能干细胞衍生的心肌细胞建立杜氏肌营养不良症心肌病模型。
Int J Mol Sci. 2023 May 12;24(10):8657. doi: 10.3390/ijms24108657.
5
Drug development progress in duchenne muscular dystrophy.杜氏肌营养不良症的药物研发进展
Front Pharmacol. 2022 Jul 22;13:950651. doi: 10.3389/fphar.2022.950651. eCollection 2022.
6
Mineralocorticoid Receptor Signaling in the Inflammatory Skeletal Muscle Microenvironments of Muscular Dystrophy and Acute Injury.盐皮质激素受体信号在肌肉萎缩症和急性损伤的炎症性骨骼肌微环境中的作用
Front Pharmacol. 2022 Jun 28;13:942660. doi: 10.3389/fphar.2022.942660. eCollection 2022.
7
Growth pattern trajectories in boys with Duchenne muscular dystrophy.男孩杜氏肌营养不良症的生长模式轨迹。
Orphanet J Rare Dis. 2022 Jan 24;17(1):20. doi: 10.1186/s13023-021-02158-9.
8
Myeloid mineralocorticoid receptors contribute to skeletal muscle repair in muscular dystrophy and acute muscle injury.髓系矿皮质激素受体有助于肌肉营养不良和急性肌肉损伤中的骨骼肌修复。
Am J Physiol Cell Physiol. 2022 Mar 1;322(3):C354-C369. doi: 10.1152/ajpcell.00411.2021. Epub 2022 Jan 19.
9
Supported Standing in Boys With Duchenne Muscular Dystrophy.杜氏肌营养不良症男孩的支撑站立
Pediatr Phys Ther. 2016 fall;28(3):320-9. doi: 10.1097/PEP.0000000000000251.
10
Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy [RETIRED]: Report of the Guideline Development Subcommittee of the American Academy of Neurology.实践指南更新摘要:杜氏肌营养不良症的皮质类固醇治疗[已退休]:美国神经病学学会指南制定小组委员会报告
Neurology. 2016 Feb 2;86(5):465-72. doi: 10.1212/WNL.0000000000002337.